Literature DB >> 7686192

Recurrence of primary biliary cirrhosis after liver transplantation following FK506-based immunosuppression.

P Y Wong1, B Portmann, J G O'Grady, J J Devlin, J E Hegarty, K C Tan, R Williams.   

Abstract

We report two cases of recurrence of primary biliary cirrhosis (PBC) in the transplanted liver whilst maintained on a FK506-based immunosuppressive regime, the first to be described. One patient experienced symptoms in association with the development of cholestasis. In both there was a persistence of serological markers of PBC and liver histology revealed florid bile duct destruction and a granulomatous reaction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686192     DOI: 10.1016/s0168-8278(05)80206-5

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  4 in total

Review 1.  Primary biliary cirrhosis and liver transplantation.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara
Journal:  Intractable Rare Dis Res       Date:  2012-05

Review 2.  Recurrence of autoimmune liver diseases after liver transplantation.

Authors:  Nabiha Faisal; Eberhard L Renner
Journal:  World J Hepatol       Date:  2015-12-18

Review 3.  Recurrent primary biliary cirrhosis after liver transplantation--the disease and its management.

Authors:  Ian Schreibman; Arie Regev
Journal:  MedGenMed       Date:  2006-05-03

4.  Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid.

Authors:  Sanjaya K Satapathy; Ollie D Jones; Jason M Vanatta; Faisal Kamal; Satish K Kedia; Yu Jiang; Satheesh P Nair; James D Eason
Journal:  Transplant Direct       Date:  2017-06-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.